{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-011197","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.974453+00:00","generated_at":"2026-05-27T05:43:26.113124+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Revelation Biosciences effects 1-for-16 reverse stock split; shares outstanding cut to ~522K","bullets":["Reverse stock split effective Jan 28, 2025, at 1-for-16 ratio; no fractional shares issued.","Approximately 522,281 shares of common stock outstanding after the split.","Proportionate adjustments made to all outstanding equity awards and warrants, except certain warrants with price reset features.","Common stock continues to trade under symbol REVB on Nasdaq; new CUSIP 76135L606.","Split approved by stockholders at Jan 17, 2025 special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-011197","json":"https://secwatch.observer/filing/0000950170-25-011197.json","markdown":"https://secwatch.observer/filing/0000950170-25-011197.md","text":"https://secwatch.observer/filing/0000950170-25-011197.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025011197/0000950170-25-011197-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025011197/revb-20250128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T05:43:26.113124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cdb30aedb565539aced99619118ba47f7864ac2e","claim":"REVELATION BIOSCIENCES, INC.: Certificate of Amendment to Third Amended and Restated Certificate of Incorporation filed to effect a 1-for-16 reverse stock split (effective 2025-01-28).","evidence_excerpt":"the Company filed a Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) effective on January 28, 2025, which effected a 1-for-16 reverse stock split as of 12:01 a.m. Eastern Standard Time on January 28, 2025","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025011197/0000950170-25-011197-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-01-28"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}